Contemporaneous chronic rejection of multiple allografts with principal pancreatic involvement in modified multivisceral transplantation

Pediatric Transplantation

Volumn 11, Issue 4, 2007, Pages 448-452

  Takahashi, Hidenori ^a   Delacruz, Victor ^a   Sarwar, Shoib ^a   Selvaggi, Gennaro ^a   Moon, Jang ^a   Nishida, Seigo ^a   Weppler, Debbie ^a   Levi, David ^a   Kato, Tomoaki ^a   Tzakis, Andreas ^a   Ruiz, Phillip ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

Chronic rejection; Organ transplantation

Indexed keywords

ALLOGRAFT; ARTICLE; CASE REPORT; CHRONIC GRAFT REJECTION; ENTERIC FEEDING; EXPLANT; GRAFT DYSFUNCTION; HIRSCHSPRUNG DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; INTESTINE GRAFT; INTESTINE OBSTRUCTION; INTRAVENOUS FEEDING; LAPAROTOMY; MALABSORPTION; MALE; PANCREAS TRANSPLANTATION; POSTOPERATIVE PERIOD; REOPERATION; SHORT BOWEL SYNDROME; TISSUE SECTION;

CHILD; CHRONIC DISEASE; DUODENUM; FOLLOW-UP STUDIES; GRAFT REJECTION; HIRSCHSPRUNG DISEASE; HUMANS; INTESTINE, LARGE; INTESTINE, SMALL; MALE; ORGAN TRANSPLANTATION; PANCREAS TRANSPLANTATION; PANCREATIC DISEASES; REOPERATION; SEVERITY OF ILLNESS INDEX;

EID: 34247581945     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2007.00703.x     Document Type: Article

References (21)

1. Parizhskaya M, Redondo C, Demetris A, et al. Chronic rejection of small bowel grafts: Pediatric and adult study of risk factors and morphologic progression. Pediatr Dev Pathol 2003 : 6 : 240 250.
2. Demetris AJ, Murase N, Lee RG, et al. Chronic rejection A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts. Ann Transplant 1997 : 2 : 27 44.
3. Waaga AM, Gasser M, Laskowski I, et al. Mechanisms of chronic rejection. Curr Opin Immunol 2000 : 12 : 517 521.
4. Inomata Y, Tanaka K. Pathogenesis and treatment of bile duct loss after liver transplantation. J Hepatobiliary Pancreat Surg 2001 : 8 : 316 322.
5. Paul LC. Immunologic risk factors for chronic renal allograft dysfunction. Transplantation 2001 : 71 : SS17 SS23.
6. Fellstrom B. Nonimmune risk factors for chronic renal allograft disfunction. Transplantation 2001 : 71 : SS10 SS16.
7. Nankivell BJ, Borrows RJ, Fung CL, et al. The natural history of chronic allograft nephropathy. N Engl J Med 2003 : 349 : 2326 2333.
8. Campos EF, Tedesco-Silva H, Machado PG, et al. Post-transplant anti-HLA class II antibodies as risk factor for late kidney allograft failure. Am J Transplant 2006 : 6 : 2316 2320.
9. Papadimitriou JC, Drachenberg CB, Klassen DK, et al. Histological grading of chronic pancreas allograft rejection/graft sclerosis. Am J Transplant 2003 : 3 : 599 605.
10. Lee RG, Nakamura K, Tsamandas AC, et al. Pathology of human intestinal transplantation. Gastroenterology 1996 : 110 : 1820 1834.
11. Humar A, Khwaja K, Ramcharan T, et al. Chronic rejection: The next major challenge for pancreas transplant recipients. Transplantation 2003 : 76 : 918 923.
12. Abu-Elmagd K, Reyes J, Bond G, et al. Clinical intestinal transplantation: A decade of experience at a single center. Ann Surg 2001 : 234 : 404 407.
13. Kato T, Tzakis AG, Selvaggi G, et al. Intestinal and multivisceral transplantation in children. Ann Surg 2006 : 243 : 756 756.
14. Perez MT, Garcia M, Weppler D, et al. Temporal relationships between acute cellular rejection features and increased mucosal fibrosis in the early posttransplant period of human small intestinal allografts. Transplantation 2002 : 73 : 555 559.
15. Moreso F, Ibernon M, Goma M, et al. Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss. Am J Transplant 2006 : 6 : 747 752.
16. Cailhier JF, Laplante P, Hebert MJ. Endothelial apoptosis and chronic transplant vasculopathy: Recent results, novel mechanisms. Am J Transplant 2006 : 6 : 247 253.
17. Calne R, Friend P, Moffatt S, et al. Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients. Lancet 1998 : 351 : 1701 1702.
18. Tzakis AG, Tryphonopoulos P, Kato T, et al. Preliminary experience with alemtuzumab (Campath-1H) and low-dose tacrolimus immunosuppression in adult liver transplantation. Transplantation 2004 : 77 : 1209 1214.
19. Tzakis AG, Kato T, Nishida S, et al. Alemtuzumab (Campath-1H) combined with tacrolimus in intestinal and multivisceral transplantation. Transplantation 2003 : 75 : 1512 1517.
20. Luckraz H, Goddard M, Mcneil K, et al. Is obliterative bronchiolitis in lung transplantation associated with microvascular damage to small airways? Ann Thorac Surg 2006 : 82 : 1212 1218.
21. Takahashi H, Selvaggi G, Nishida S, et al. Organ-specific differences in acute rejection intensity in a multivisceral transplant. Transplantation 2006 : 81 : 297 299.